Research / NVT / Fundamental state Inspectable configuration
State dimensions Filing 0001720635-21-000026 General Corporate
Debt relative to revenue 42th Own-history percentile · N=12
Evidence method Level · gp.fundamentals.debt_to_revenue
168.19% · OPTIONAL · VALID
Capex intensity 67th Own-history percentile · N=12
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.80% · OPTIONAL · VALID
Operating cash generation 33th Own-history percentile · N=12
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
9.09% · OPTIONAL · VALID
Share-count growth 63th Own-history percentile · N=8
Evidence method Yoy · gp.fundamentals.shares_outstanding
-1.28% · CORE · VALID
Revenue growth 100th Own-history percentile · N=8
Evidence method Yoy · gp.fundamentals.revenue
5.38% · CORE · VALID
Inventory pressure 50th Own-history percentile · N=12
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
43.34% · OPTIONAL · VALID
Gross margin 25th Own-history percentile · N=12
Evidence method Level · gp.fundamentals.gross_margin
38.08% · CORE · VALID
Operating margin 67th Own-history percentile · N=12
Evidence method Level · gp.fundamentals.operating_margin
14.65% · CORE · VALID
R&D intensity 33th Own-history percentile · N=12
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.08% · OPTIONAL · VALID
SBC intensity 0th Own-history percentile · N=12
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
-0.04% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Sep 30, 2021 10/10 normalized Level 3 Dec 31, 2021 10/10 normalized Level 3 Mar 31, 2022 10/10 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 10/10 normalized Level 3 Mar 31, 2023 10/10 normalized Level 3 Jun 30, 2023 10/10 normalized Level 3 Sep 30, 2023 10/10 normalized Level 3 Dec 31, 2023 10/10 normalized Level 3 Mar 31, 2024 10/10 normalized Level 3 Jun 30, 2024 10/10 normalized Level 3 Sep 30, 2024 10/10 normalized Level 3 Dec 31, 2024 10/10 normalized Level 3 Mar 31, 2025 10/10 normalized Level 3 Jun 30, 2025 10/10 normalized Level 3 Sep 30, 2025 10/10 normalized Level 3 Dec 31, 2025 10/10 normalized Level 3 Mar 31, 2026 10/10 normalized Level 3 Jun 30, 2026 10/10 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 47.43%
Current 168.19%
Delta 120.76% Capex Intensity Decreased
Previous 2.00%
Current 1.80%
Delta -0.20% Cash Generation Decreased
Previous 17.21%
Current 9.09%
Delta -8.12% Dilution Decreased
Previous -0.77%
Current -1.28%
Delta -0.51% Growth Increased
Previous -9.32%
Current 5.38%
Delta 14.69% Inventory Pressure Increased
Previous 11.77%
Current 43.34%
Delta 31.57% Margin Increased
Previous 37.50%
Current 38.08%
Delta 0.58% Profitability Increased
Previous 1.92%
Current 14.65%
Delta 12.73% R And D Intensity Decreased
Previous 2.18%
Current 2.08%
Delta -0.10% Sbc Intensity Decreased
Previous 0.70%
Current -0.04%
Delta -0.73% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.